Neutrophils as a pallbearer for SARS-CoV-2 disease burden - Authors' reply.
作者信息
Lutter René, Schurink Bernadette, Roos Eva, Guo Lihui, van der Valk Paul, Bugiani Marianna
机构信息
Department of Respiratory Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam 1105 AZ, The Netherlands.
Experimental Immunology, Amsterdam UMC, University of Amsterdam, Amsterdam 1105 AZ, The Netherlands.
出版信息
Lancet Microbe. 2021 Feb;2(2):e57. doi: 10.1016/S2666-5247(21)00001-X. Epub 2021 Feb 2.
Abstract
摘要
相似文献
1
Neutrophils as a pallbearer for SARS-CoV-2 disease burden - Authors' reply.中性粒细胞作为新冠病毒疾病负担的“抬棺人”——作者回复
Lancet Microbe. 2021 Feb;2(2):e57. doi: 10.1016/S2666-5247(21)00001-X. Epub 2021 Feb 2.
2
Neutrophils as a pallbearer for SARS-CoV-2 disease burden.中性粒细胞作为新冠病毒疾病负担的“抬棺人” 。
Lancet Microbe. 2021 Feb;2(2):e56. doi: 10.1016/S2666-5247(21)00002-1. Epub 2021 Feb 2.
3
The ability of the neonatal immune response to handle SARS-CoV-2 infection - Authors' reply.新生儿免疫反应应对新型冠状病毒2感染的能力——作者回复
Lancet Child Adolesc Health. 2021 Mar;5(3):e8. doi: 10.1016/S2352-4642(21)00004-3. Epub 2021 Jan 21.
4
Activation of Type I and Type II Interferon Signaling in SARS-CoV-2-Positive Thyroid Tissue of Patients Dying from COVID-19.COVID-19 死亡患者新冠病毒阳性甲状腺组织中 I 型和 II 型干扰素信号的激活。
Thyroid. 2021 Dec;31(12):1766-1775. doi: 10.1089/thy.2021.0345.
5
Toward a clinically based classification of disease severity for paediatric COVID-19 - Authors' reply.关于儿童新型冠状病毒肺炎疾病严重程度基于临床的分类——作者回复
Lancet Infect Dis. 2021 Jan;21(1):22-23. doi: 10.1016/S1473-3099(20)30397-2. Epub 2020 May 15.
6
Authors' Reply.作者回复。
J Am Soc Nephrol. 2020 Sep;31(9):2225-2226. doi: 10.1681/ASN.2020060847. Epub 2020 Aug 12.
7
ECMO support for COVID-19: a balancing act - Authors' reply.体外膜肺氧合（ECMO）对新型冠状病毒肺炎（COVID-19）的支持：权衡之举——作者回复
Lancet. 2021 Jan 9;397(10269):95. doi: 10.1016/S0140-6736(20)32517-4.
8
Microvascular disease in diabetes and severe COVID-19 outcomes - Authors' reply.糖尿病中的微血管疾病与严重的新冠病毒病结局——作者回复
Lancet Diabetes Endocrinol. 2021 Apr;9(4):201. doi: 10.1016/S2213-8587(21)00055-3.
9
Using the neutrophil-to-lymphocyte ratio to estimate the severity of coronavirus disease 2019. Authors' reply.利用中性粒细胞与淋巴细胞比值评估2019冠状病毒病的严重程度。作者回复。
Pol Arch Intern Med. 2020 Aug 27;130(7-8):717-718. doi: 10.20452/pamw.15582.
10
Pathophysiology of COVID-19-associated acute respiratory distress syndrome - Authors' reply.新型冠状病毒肺炎相关急性呼吸窘迫综合征的病理生理学——作者回复
Lancet Respir Med. 2021 Jan;9(1):e5-e6. doi: 10.1016/S2213-2600(20)30525-7. Epub 2020 Nov 13.
引用本文的文献
1
Indoleamine 2,3-dioxygenase (IDO)-1 and IDO-2 activity and severe course of COVID-19.吲哚胺 2,3-双加氧酶（IDO）-1 和 IDO-2 的活性与 COVID-19 的严重病程。
J Pathol. 2022 Mar;256(3):256-261. doi: 10.1002/path.5842. Epub 2022 Jan 10.
本文引用的文献
1
Circulating Markers of Neutrophil Extracellular Traps Are of Prognostic Value in Patients With COVID-19.中性粒细胞胞外诱捕网的循环标志物对COVID-19患者具有预后价值。
Arterioscler Thromb Vasc Biol. 2021 Feb;41(2):988-994. doi: 10.1161/ATVBAHA.120.315267. Epub 2020 Dec 3.
2
Rhinovirus-16 induced temporal interferon responses in nasal epithelium links with viral clearance and symptoms.鼻病毒 16 诱导鼻上皮细胞的暂时干扰素反应与病毒清除和症状有关。
Clin Exp Allergy. 2019 Dec;49(12):1587-1597. doi: 10.1111/cea.13481. Epub 2019 Oct 31.
3
IL-33 drives influenza-induced asthma exacerbations by halting innate and adaptive antiviral immunity.IL-33 通过阻断先天和适应性抗病毒免疫来驱动流感诱导的哮喘恶化。
J Allergy Clin Immunol. 2019 Apr;143(4):1355-1370.e16. doi: 10.1016/j.jaci.2018.08.051. Epub 2018 Oct 12.
4
High Level of Neutrophil Extracellular Traps Correlates With Poor Prognosis of Severe Influenza A Infection.中性粒细胞胞外诱捕网水平与严重甲型流感感染的不良预后相关。
J Infect Dis. 2018 Jan 17;217(3):428-437. doi: 10.1093/infdis/jix475.
5
Host DNA released by NETosis promotes rhinovirus-induced type-2 allergic asthma exacerbation.由中性粒细胞胞外陷阱形成释放的宿主DNA促进鼻病毒诱导的2型过敏性哮喘加重。
Nat Med. 2017 Jun;23(6):681-691. doi: 10.1038/nm.4332. Epub 2017 May 1.
Zotero 插件